39 medicines added to list of essentials, prices to come down

NEW DELHI: In a move that may bring down prices of some widely used essential drugs, the government has revised the National List of Essential Medicines, adding 39 new ones under the list for proposed price cap, a source said. Those that have been added to the list include drugs to fight cancer, diabetes, tuberculosis and HIV apart from some antivirals.

The government has also deleted 16 drugs from the existing list and the final NLEM 2021 now contains 399 essential medicines, up from 376 drugs that are currently under direct price control.

The revised list, prepared by an expert committee under the Indian Council of Medical Research, was submitted to health minister Mansukh Mandaviya on Thursday. Once the list is notified by the health ministry, it will be evaluated by the Standing Committee on Affordable Medicines and Health Products (SCAMHP) to assess which of the medicines require price capping.

The final price capping will be done by the National Pharmaceutical Pricing Authority based on the recommendations of the SCAMHP, headed by Niti Aayog member-health Dr V K Paul.

Those that have been added to the list include drugs to fight cancer, diabetes, tuberculosis and HIV apart from some antivirals.

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre